胆汁淤积性肝病的病因

doi:10.3969/j.issn.1672-5069.2016.06.002

Abstract

Shen Feifei，Lu Lungen.. Etiology of cholestatic liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 644-646.

[1] Beuers U，Trauner M，Jansen P，et a1. New paradigms in the treatment of hepatic cholestasis:from UDCA to FXR，PXR and beyond. J Hepatol，2015，62（IS）:S25-S37.
[2] Kuntze E，Kuntz HD. Hepatplogy:principles and practice. 2nd ed. Spriger Medizin Verlag Herdelberg，2006:227-242.
[3] Bortolini M，Almasio P，Bray G，et al．Multicentre survey of the prevalence of intrahepatic cholestasis in 2520 consecutive patients with newly diagnosed chronic liver disease．Drag Invest，1992，4（Suppl 4）：83-89.
[4] 曹旬旬，高月求，张文宏，等. 基于上海市住院慢性肝病患者胆汁淤积患病率的调查研究. 中华肝脏病杂志，2015，23（8）: 569-573.
[5] Burt AD，Portman BC，Ferrell LD. MacSween’s pathology of the liver. 6th ed. Spriger Medizin Verlag Herdelberg，2012:503-562.
[6] Bacon BR，O’Grady JG，Di Biscglie AM，et al. Comprehensive clinical hepatology. 2nd ed. Elsiver，2006:87.
[7] European Association for the Study of the Liver. EASL clinical practice guidelines:management of cholestatic liver diseases. J Hepatol，2009，51（2）:237-267.
[8] Bhogal HK，Sanyal AJ. The molecular pathogenesis of cholestasis in sepsis. Front Biosci （Elite Ed），2013，E5（1）:87-96.
[9] Elferink MG，Olinga P，Draaisma AL，et a1．LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process．Am J Physiol Gastrointest Liver Physiol，2004，287（5）:Gl008-1016．
[10] Wang K. Molecular mechanisms of liver injury: apoptosis or necrosis. Exp Toxicol Pathol，2014，66（8）:351-356.
[11] Sorrentino P，Tarantino G，Perrella A，et al. A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease．Dig Dis Sci，2005，50（6）: 1130-1135．

[1]	Ding Limin, Wang Fei, Piao Lianshu, et al.. Etiology of 202 patients with abnormal liver function tests [J]. Journal of Practical Hepatology, 2019, 22(6): 856-859.
[2]	Tang Renyi, Hu Qunfeng, Peng Liqing.. Changes of serum lipids, liver function tests and estrogen levels in patients with intrahepatic cholestasis of pregnancy and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(6): 860-863.
[3]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[4]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[5]	Lu Lungen. Cholestatic liver diseases：What we know and how to deal with [J]. Journal of Practical Hepatology, 2019, 22(5): 754-757.
[6]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[7]	Yan Lingling, Hu Donghui, Huang Yanfang. Influence of ademetionine combined with polyene phosphatidylcholine on clinical efficacy and laboratory index in patients with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 530-533.
[8]	Cui Ruibing, Yan Ming.. Etiology of ascites:what’s going on [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 657-660.
[9]	Liang Jing, Han Tao.. Highlights of diagnosis and evaluation of ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 661-664.
[10]	Chen Shiyao, Huang Xiaoquan, Ceng Xiaoqing. Etiology and diagnosis of portal hypertension [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 321-324.
[11]	Zhang Yanhong, Li You, Chen Long, et al. Etiology and complications in 2890 patients with liver cihhrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 344-347.
[12]	Chen Xiaoqing, Wang Yinchun. Etiology and treatment of intrahepatic cholestatic liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 163-165.
[13]	Wang Peiwen, Dong Yuwei, Li Zhenghong, et al. Clinicopathological analysis of 94 patients with unexplained abnormal liver function tests [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 225-228.
[14]	Xiong Qingfang, Yang Yongfeng. Diagnosis of patients with unknown cause cholestasis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 18-20.
[15]	Sun Lin, Wang Dan, Wu Donghan. Impact of intrahepatic cholestasis of pregnancyon the outcomes of infants [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 133-134.

Etiology of cholestatic liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments